Literature DB >> 11435802

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.

S Overeem1, E Mignot, J G van Dijk, G J Lammers.   

Abstract

Narcolepsy is characterized by excessive daytime sleepiness and abnormal manifestations of rapid eye movement sleep such as cataplexy. The authors review the clinical features of narcolepsy, including epidemiology, symptoms, diagnosis, and treatment, in detail. Recent findings show that a loss of hypocretin-producing neurons lies at the root of the signs and symptoms of narcolepsy. The authors review the current state of knowledge on hypocretin anatomy, physiology, and function with special emphasis on the research regarding the hypocretin deficiency in narcolepsy, which may also explain associated features of the disorder, such as obesity. Lastly, they discuss some future perspectives for research into the pathophysiology of sleep/wake disorders, and the potential impact of the established hypocretin deficiency on the diagnosis and treatment of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435802     DOI: 10.1097/00004691-200103000-00002

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  51 in total

1.  Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.

Authors:  Christian Siebold; Bjarke E Hansen; Jessica R Wyer; Karl Harlos; Robert E Esnouf; Arne Svejgaard; John I Bell; Jack L Strominger; E Yvonne Jones; Lars Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 2.  Narcolepsy and excessive daytime sleepiness.

Authors:  Adam Zeman; Tom Britton; Neil Douglas; Andrew Hansen; Jane Hicks; Robin Howard; Andrew Meredith; Ian Smith; Gregory Stores; Sue Wilson; Zenobia Zaiwalla
Journal:  BMJ       Date:  2004-09-25

Review 3.  Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Authors:  Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

Review 4.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

Review 6.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

7.  Narcolepsy in African Americans.

Authors:  Makoto Kawai; Ruth O'Hara; Mali Einen; Ling Lin; Emmanuel Mignot
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

8.  Near-death experiences--Neuroscience perspectives on near-death experiences.

Authors:  Kevin Nelson
Journal:  Mo Med       Date:  2015 Mar-Apr

Review 9.  Genetic association, seasonal infections and autoimmune basis of narcolepsy.

Authors:  Abinav Kumar Singh; Josh Mahlios; Emmanuel Mignot
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

10.  High frequency repetitive transcranial magnetic stimulation over the motor cortex: No diagnostic value for narcolepsy/cataplexy.

Authors:  S Overeem; J Afink; M Bakker; G J Lammers; M Zwarts; B R Bloem; J G van Dijk
Journal:  J Neurol       Date:  2007-06-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.